Theramx -AI-based Semiconductor Lab-on-a-Chip (LOC) Technology
Biosensing technology that enables early diagnosis and prevention of diseases through an analysis of complex causal substances (proteins, lipids, organic acids, etc.) for dementia or metabolic syndrome, etc., as well as analysis/detection of composite biomarkers utilizing AI technology.
Theramx retains nanocomposite synthesis technology, FET (Field Emission Transistor) manufacturing technology, MEMS (Micro Electro Mechanical Systems) technology, optical sensing technology, and array-type data generation technology required for the completion of LOC manufacturing technology based on semiconductor chips, in conjunction with a specialized research team. In addition, Theramx holds competency in biomarker discovery from LOC data maps through the application of AI technology of our partner company, AZB.
